FDA Approves Johnson & Johnson Vision’s Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management

By Staff
Thursday, May 13, 2021 12:24 AM JACKSONVILLE, Fla.—Johnson & Johnson Vision said Wednesday that the Food and Drug Administration (FDA) has approved Acuvue Abiliti Overnight Therapeutic Lenses. This new lens is the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia, according to the announcement. The lens, expected to launch by the end of 2021, will be available in sphere and toric designs to correct various combinations of corneal shapes and refractive errors. ECPs and parents who want more information can visit the site here.

Shamir and Alpine F1 Team Form New Partnership

By Staff
Tuesday, May 11, 2021 12:24 AM SAN DIEGO—Shamir and Alpine Formula 1 have formed a new partnership which will see Shamir become the Alpine F1 Team's optical performance partner.

Kits Announces Upgrade to the OTCQX Best Market in the U.S.

By Staff
Monday, May 10, 2021 12:15 AM VANCOUVER—Kits Eyecare Ltd. (TSX: KITS), the vertically integrated, digital eyecare platform backed by the investor Roger Hardy, has been approved for immediate trading on the OTCQX Best Market, the top tier of the OTC Markets. Shares of the company were upgraded to OTCQX from the Pink market, according to an announcement late last week. Kits Eyecare began trading Friday (May 7) on OTCQX under the symbol “KTYCF.” In its announcement, Kits Eyecare said “upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors.” (Kits Eyecare has been listed on the Toronto Stock Exchange since the beginning of this year.)

CooperVision Seeks Proposals for 2021 Science and Technology Awards

By Staff
Thursday, May 6, 2021 12:18 AM SAN RAMON, Calif.—To drive innovation in the industry through continuous contact lens research and development, CooperVision is now accepting submissions for its 2021 Science and Technology Awards program. The long-standing program fosters partnerships between recipients and CooperVision scientists to explore new dimensions in vision care, with the goal of translating innovative ideas into practical solutions. “As a leading global manufacturer of contact lenses, CooperVision has brought to market many breakthrough products, but we never stop raising the bar and working for what comes next,” said Francis Erard, CooperVision’s vice president of research & development.

Bausch Health Reports Slight Sales Gain in First Quarter and Provides Details on Expected Leadership Team for B+L Business

By Staff
Wednesday, May 5, 2021 12:27 AM LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) reported Tuesday that its full-company revenue rose 1 percent (or $15 million) in the first quarter to $2.027 billion from $2.012 billion in the year-ago period.

FYidoctors Named Canadian Partner for Launch of J&J Vision’s Acuvue Theravision With Ketotifen for Allergic Eye Itch

By Staff
Monday, May 3, 2021 12:27 AM CALGARY, Alberta—FYidoctors, an optometrist-controlled eyecare company based here, said it has received exclusive Canadian “in-market assessment access for 2021” for the new Johnson & Johnson Vision contact lens: Acuvue Theravision with Ketotifen. The new lens, which was approved in Canada last week, is the first and only drug-releasing contact lens for vision correction and allergic eye itch, according to the announcement last week.

Bausch Health May Consider Potential Sale of the Bausch + Lomb Eyecare Business, According to Report

By Staff
Friday, April 30, 2021 12:39 AM Bausch Health may sell B+L eyecare biz, Eye Health America continues Southeast expansion, optical sales continue to decline, Jobson Tracker says, EssilorLuxottica to exhibit at Expo as fully integrated company and more than 200 exhibitors commit to Vision Expo East all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

Bausch Health May Consider Potential Sale of the Bausch + Lomb Eyecare Business, According to Report

By Staff
Friday, April 30, 2021 12:36 AM LAVAL, Quebec—Bausch Health Companies (NYSE/TSX: BHC) is weighing the potential sale of its Bausch + Lomb eyecare business, rather than spinning off the business to shareholders as the company planned, according to a Bloomberg report earlier this week. The news service cited “people with knowledge of the matter” as the origin of its report. Bausch Health declined comment on the report, a spokeswoman told VMAIL.

Alcon Opens SECO Conference With Discussion of Innovation, New Products and Support for ECPs

By Staff
Thursday, April 29, 2021 12:21 AM ATLANTA—The annual SECO meeting opened in Atlanta on Wednesday and Alcon was among the companies organizing both in-person and virtual meetings with ECPs and industry professionals.

Three-Year Study Shows Hoya MiyoSmart Lens Slows Myopia Progression in Children

By Staff
Wednesday, April 28, 2021 12:27 AM BANGKOK—The results of a new study showed that Hoya Vision Care’s MiyoSmart lens slowed myopia progression in children over a three-year period. Hoya Vision Care announced the results of the three-year follow-up clinical study on its MiyoSmart spectacle lens with patented Defocus Incorporated Multiple Segments.

CooperVision Acquires No7 Contact Lenses to Expand Specialty EyeCare Business and Establish Direct-to-ECP Presence in the U.K.

By Staff
Wednesday, April 28, 2021 12:21 AM FAREHAM, United Kingdom—CooperVision reported Tuesday that it has acquired No7 Contact Lenses, which is based here. No7 Contact Lenses designs and manufactures specialty contact lenses that are distributed primarily in the United Kingdom.

Health Canada Approves Johnson & Johnson Vision’s Acuvue Theravision With Ketotifen for Itchy, Allergy Eyes

By Staff
Wednesday, April 28, 2021 12:18 AM JACKSONVILLE, Fla.—Johnson & Johnson Vision, a leader in eye health and part of the Johnson & Johnson Medical Devices Companies, received Health Canada approval for its Acuvue Theravision with Ketotifen, the first and only daily disposable contact lens for vision correction in patients who experience itchy allergy eyes due to allergic conjunctivitis, according to the company’s announcement Tuesday. The lens contains an H1 histamine receptor antagonist for the prevention of itchy allergy eyes associated with allergic conjunctivitis experienced by contact lens users to promote comfortable contact lens wear.

Rodenstock Lenses to Be Distributed in Canada by Centennial Optical, Effective May 2021

By Staff
Friday, April 23, 2021 12:15 AM MUNICH and TORONTO—Rodenstock GmbH and Centennial Optical Limited have announced a new distribution agreement for Rodenstock lenses in Canada, which takes effect in May 2021. Rodenstock digitally customized lenses will be available through Centennial Optical to Canadian eyecare professionals and optical laboratories. “This new partnership represents an opportunity for Canadian eyecare professionals to grow their practices with a premium brand and industry-leading lens technology,” said Mike Jones, vice president, lens sales for Centennial. “We’re very excited to be able to offer this highly respected optical brand to our customers in Canada,” added Allen Nightingale, president of Centennial Optical.

Johnson & Johnson Reports Strong First Quarter as Medical Devices Segment Sees ‘Continued Recovery’

By Staff
Wednesday, April 21, 2021 12:18 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) reported Tuesday that its first-quarter sales increased 7.9 percent to $22.3 billion, with operational sales growth of 5.5 percent.

CooperVision Offers Optometry Students New Opportunities, Further Commits to Myopia Management Education

By Staff
Tuesday, April 20, 2021 12:24 AM SAN RAMON, Calif.—Committed to furthering myopia management education in the optometric industry, CooperVision is bringing new opportunities to optometry students. Certification for its Brilliant Futures Myopia Management Program featuring MiSight 1 day contact lenses is now available to third- and fourth-year students at the 23 schools and colleges of optometry throughout the U.S.